Back
Tarsus Pharmaceuticals Quote, Financials, Valuation and Earnings
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
84
TARS
Tarsus Pharmaceuticals
Last Price:
44.62
Seasonality Move:
37.14%
7 Day Trial
ALL ACCESS PASS
$
7
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.Tarsus Pharmaceuticals Price Quote
$44.62
+0.75 (+1.71%)
(Updated: October 30, 2024 at 6:55 PM ET)
Tarsus Pharmaceuticals Key Stats
Buy
84
Tarsus Pharmaceuticals (TARS)
is a Buy
Day range:
$38.90 - $46.71
52-week range:
$13.90 - $46.71
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.03
P/B ratio:
6.62%
Volume:
3M
Avg. volume:
672.9K
1-year change:
218.82%
Market cap:
$1.7B
Revenue:
$17.4M
EPS:
$-4.48
How Much Does Tarsus Pharmaceuticals Make?
-
How Much Are Tarsus Pharmaceuticals's Sales Annually?
TARS Revenues are $17.4M -
How Much Profit Does Tarsus Pharmaceuticals's Make A Year?
TARS net income is -$135.9M
Is Tarsus Pharmaceuticals Growing As A Company?
Data Unavailable
Tarsus Pharmaceuticals Stock Price Performance
-
Did Tarsus Pharmaceuticals Stock Go Up Last Month?
Tarsus Pharmaceuticals share price went up by 34.94% last month -
Did TARS's Share Price Rise Over The Last Year?
TARS share price rose by 218.82% over the past 1 year
What Is Tarsus Pharmaceuticals 52-Week High & Low?
-
What Is Tarsus Pharmaceuticals’s 52-Week High Share Price?
Tarsus Pharmaceuticals has traded as high as $46.71 over the past 52 weeks -
What Is Tarsus Pharmaceuticals’s 52-Week Low Share Price?
Tarsus Pharmaceuticals has traded as low as $13.90 over the past 52 weeks
Tarsus Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Tarsus Pharmaceuticals?
-
How Much Debt Does Tarsus Pharmaceuticals Have?
Total long term debt quarterly is $71.6M -
How Much Cash Does Tarsus Pharmaceuticals Have?
Cash and short term investments quarterly total is $323.6M -
What Is Tarsus Pharmaceuticals’s Book Value Per Share?
Book value per share is 6.63
Is Tarsus Pharmaceuticals Cash Flow Positive?
-
What Is TARS Cash Flow From Operations?
Cash flow from operations (TTM) is -$123.9M -
What Is Tarsus Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $275.7M -
What Is Tarsus Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$77.5M
Tarsus Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
TARS return on invested capital is -59.01% -
What Is Tarsus Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -51.79% -
What Is TARS Return On Equity?
ROE is a measure of profitability and is -69.1%
Tarsus Pharmaceuticals Earnings Date & Stock Price
-
What Is Tarsus Pharmaceuticals's Stock Price Today?
A single share of TARS can be purchased today for 43.87 -
What Is Tarsus Pharmaceuticals’s Stock Symbol?
Tarsus Pharmaceuticals trades on the nasdaq under the ticker symbol: TARS -
When Is Tarsus Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Tarsus Pharmaceuticals is scheduled on November 8, 2024 -
When Is TARS's next ex-dividend date?
Tarsus Pharmaceuticals's next ex-dividend date is October 31, 2024 -
How To Buy Tarsus Pharmaceuticals Stock?
You can buy Tarsus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Tarsus Pharmaceuticals Competitors
-
Who Are Tarsus Pharmaceuticals's Competitors?
Below is a list of companies who compete with Tarsus Pharmaceuticals or are related in some way:
Tarsus Pharmaceuticals Dividend Yield
-
What Is TARS Dividend Yield?
Tarsus Pharmaceuticals’s dividend yield currently is 0% -
What Is Tarsus Pharmaceuticals’s Payout Ratio?
Tarsus Pharmaceuticals’s payout ratio is 0% -
When Did Tarsus Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is October 31, 2024 -
What Is Tarsus Pharmaceuticals’s Dividend Per Share?
Tarsus Pharmaceuticals pays a dividend of $0.00 per share
Tarsus Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -3.8% |
| Revenue: | 0% | 27.35% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 59.33 |
| Upside from Last Price: | 35.25% |